Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy

Oral Oncology , 05/25/2012

This study suggests that patients with advanced laryngeal tumors who historically had been considered poor candidates for organ–sparing treatment are able to return to, and in many cases exceed pre–treatment performance and quality–of–life (QOL) following induction chemotherapy and combined chemoradiotherapy.

Print Article Summary Cat 2 CME Report